Evaluation of Mid- and Long-term Impact of COVID-19 on Male Fertility Through Evaluating Semen Parameters

Overview

Journal Transl Androl Urol

Date 2022 Mar 14

PMID 35280660

Authors

Bintao Hu

Kang Liu

Yajun Ruan

Xian Wei

Yue Wu

Huan Feng

Zhiyao Deng

Jihong Liu

Tao Wang

Affiliations

Soon will be listed here.

Abstract

Background: The coronavirus disease 2019 (COVID-19) has spread worldwide with alarming levels of spread and severity. The distribution of angiotensin converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2) from bioinformatics evidence, the autopsy report for COVID-19 and the published study on sperm quality indicated COVID-19 could have a negative impact on male fertility. However, whether the negative impact of COVID-19 on male fertility is persistent remains unknown, which requires long-term follow-up investigation.

Methods: Semen samples were collected from 36 male COVID-19 patients with a median recovery time of 177.5 days and 45 control subjects. Then, analysis of sperm quality and alterations of total sperm number with recovery time were performed.

Results: There was no significant difference in semen parameters between male recovered patients and control subjects. And the comparisons of semen parameters between first follow-up and second follow-up revealed no significant difference. In addition, we explored the alterations of sperm count with recovery time. It showed that the group with recovery time of ≥120 and <150 days had a significantly lower total sperm number than controls while the other two groups with recovery time of ≥150 days displayed no significance with controls, and total sperm number showed a significant decline after a recovery time of 90 days and an improving trend after a recovery time of about 150 days.

Conclusions: The sperm quality of COVID-19 recovered patients improved after a recovery time of nearly half a year, while the total sperm number showed an improvement after a recovery time of about 150 days. COVID-19 patients should pay close attention to the quality of semen, and might be considered to be given medical interventions if necessary within about two months after recovery, in order to improve the fertility of male patients as soon as possible.

Citing Articles

SARS-CoV-2-induced cytokine storm drives prolonged testicular injury and functional impairment in mice that are mitigated by dexamethasone.

Giannakopoulos S, Pak J, Bakse J, Ward M, Nerurkar V, Tallquist M PLoS Pathog. 2025; 21(1):e1012804.

PMID: 39775442 PMC: 11706467. DOI: 10.1371/journal.ppat.1012804.

Impact of SARS-CoV-2 on the male reproductive tract: insights from semen analysis and cryopreservation.

Giugliano S, Mozzarelli A, Navarra A, De Simone G, Rescigno M, Levi-Setti P J Assist Reprod Genet. 2024; 42(2):577-587.

PMID: 39699717 PMC: 11871218. DOI: 10.1007/s10815-024-03321-4.

The temporary impact of COVID-19 on semen deoxyribonucleic acid fragmentation.

Kvach M, Nikitin O, Kost A, Banyra O Cent European J Urol. 2024; 77(2):298-303.

PMID: 39345316 PMC: 11428368. DOI: 10.5173/ceju.2024.263.

A Systemic Review and Meta-analysis of the Effect of SARS-CoV-2 Infection on Sperm Parameters.

Chen X, Ding J, Liu M, Xing K, Ye P, Min J Research (Wash D C). 2024; 2022:9835731.

PMID: 39301505 PMC: 11412417. DOI: 10.34133/2022/9835731.

SARS-CoV-2 impairs male fertility by targeting semen quality and testosterone level: A systematic review and meta-analysis.

V J A, P J A, T M A, Akhigbe R PLoS One. 2024; 19(9):e0307396.

PMID: 39250513 PMC: 11383251. DOI: 10.1371/journal.pone.0307396.

References

Lu R, Zhao X, Li J, Niu P, Yang B, Wu H . Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020; 395(10224):565-574. PMC: 7159086. DOI: 10.1016/S0140-6736(20)30251-8. View

Bhushan S, Schuppe H, Fijak M, Meinhardt A . Testicular infection: microorganisms, clinical implications and host-pathogen interaction. J Reprod Immunol. 2009; 83(1-2):164-7. DOI: 10.1016/j.jri.2009.07.007. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Yang M, Chen S, Huang B, Zhong J, Su H, Chen Y . Pathological Findings in the Testes of COVID-19 Patients: Clinical Implications. Eur Urol Focus. 2020; 6(5):1124-1129. PMC: 7261470. DOI: 10.1016/j.euf.2020.05.009. View

Pan F, Xiao X, Guo J, Song Y, Li H, Patel D . No evidence of severe acute respiratory syndrome-coronavirus 2 in semen of males recovering from coronavirus disease 2019. Fertil Steril. 2020; 113(6):1135-1139. PMC: 7164916. DOI: 10.1016/j.fertnstert.2020.04.024. View

Holtmann N, Edimiris P, Andree M, Doehmen C, Baston-Buest D, Adams O . Assessment of SARS-CoV-2 in human semen-a cohort study. Fertil Steril. 2020; 114(2):233-238. PMC: 7256599. DOI: 10.1016/j.fertnstert.2020.05.028. View

Gralinski L, Menachery V . Return of the Coronavirus: 2019-nCoV. Viruses. 2020; 12(2). PMC: 7077245. DOI: 10.3390/v12020135. View

Sergerie M, Mieusset R, Croute F, Daudin M, Bujan L . High risk of temporary alteration of semen parameters after recent acute febrile illness. Fertil Steril. 2007; 88(4):970.e1-7. DOI: 10.1016/j.fertnstert.2006.12.045. View

Carfi A, Bernabei R, Landi F . Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020; 324(6):603-605. PMC: 7349096. DOI: 10.1001/jama.2020.12603. View

10.

Li H, Xiao X, Zhang J, Zafar M, Wu C, Long Y . Impaired spermatogenesis in COVID-19 patients. EClinicalMedicine. 2020; 28:100604. PMC: 7584442. DOI: 10.1016/j.eclinm.2020.100604. View

11.

Masarani M, Wazait H, Dinneen M . Mumps orchitis. J R Soc Med. 2006; 99(11):573-5. PMC: 1633545. DOI: 10.1177/014107680609901116. View

12.

Paoli D, Pallotti F, Turriziani O, Mazzuti L, Antonelli G, Lenzi A . SARS-CoV-2 presence in seminal fluid: Myth or reality. Andrology. 2020; 9(1):23-26. PMC: 7283802. DOI: 10.1111/andr.12825. View

13.

Pascolo L, Zito G, Zupin L, Luppi S, Giolo E, Martinelli M . Renin Angiotensin System, COVID-19 and Male Fertility: Any Risk for Conceiving?. Microorganisms. 2020; 8(10). PMC: 7601043. DOI: 10.3390/microorganisms8101492. View

14.

Hoffmann M, Kleine-Weber H, Schroeder S, Kruger N, Herrler T, Erichsen S . SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020; 181(2):271-280.e8. PMC: 7102627. DOI: 10.1016/j.cell.2020.02.052. View

15.

Gheblawi M, Wang K, Viveiros A, Nguyen Q, Zhong J, Turner A . Angiotensin-Converting Enzyme 2: SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System: Celebrating the 20th Anniversary of the Discovery of ACE2. Circ Res. 2020; 126(10):1456-1474. PMC: 7188049. DOI: 10.1161/CIRCRESAHA.120.317015. View

16.

Liu W, Han R, Wu H, Han D . Viral threat to male fertility. Andrologia. 2018; 50(11):e13140. DOI: 10.1111/and.13140. View

17.

Salam A, Horby P . The Breadth of Viruses in Human Semen. Emerg Infect Dis. 2017; 23(11):1922-1924. PMC: 5652425. DOI: 10.3201/eid2311.171049. View

18.

Cooper T, Noonan E, von Eckardstein S, Auger J, Baker H, Behre H . World Health Organization reference values for human semen characteristics. Hum Reprod Update. 2009; 16(3):231-45. DOI: 10.1093/humupd/dmp048. View

19.

Wang Z, Xu X . scRNA-seq Profiling of Human Testes Reveals the Presence of the ACE2 Receptor, A Target for SARS-CoV-2 Infection in Spermatogonia, Leydig and Sertoli Cells. Cells. 2020; 9(4). PMC: 7226809. DOI: 10.3390/cells9040920. View

20.

Ma L, Xie W, Li D, Shi L, Ye G, Mao Y . Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients. J Med Virol. 2020; 93(1):456-462. PMC: 7361404. DOI: 10.1002/jmv.26259. View